NEW YORK (
CHANGE IN RATINGS
was downgraded at BMO Capital to underperform from market perform. Valuation call, based on a $22 price target, BMO Capital said.
was upgraded at BMO Capital to outperform from market perform. $240 price target. Company could see an expansion of the eBay partnership and has exposure to the growing auto sector, BMO Capital said.
was downgraded at Robert Baird to neutral from outperform. Valuation call, as the stock is up 73% year to date, Baird said.
was upgraded at Sterne Agee to neutral. Estimates were also boosted, given an expected commercial construction recovery, Sterne Agee said.
was downgraded at Wells Fargo to market perform from outperform. Traffic trends will likely remain weak, Wells Fargo said.
was downgraded at ISI Group to sell from cautious. Valuation call, based on a $34 price target, ISI Group said.
21st Century Fox
was initiated with an overweight rating at J.P. Morgan. $39 price target. Impressive mix of businesses, J.P. Morgan said.
was downgraded at Deutsche Bank to hold from buy. Valuation call, as the stock is up 50% over the past year, Deutsche Bank said. $50 price target.
was upgraded to buy at TheStreet Ratings.
was initiated with a neutral rating at J.P. Morgan. $37 price target. Validated platform and attractive pipeline, but valuation is rich, J.P. Morgan said.
was downgraded at CRT Capital to fair value from buy. AMR merger is facing increased legal scrutiny, CRT Capital said.
was upgraded at Compass Point to buy from neutral. Valuation call, based on a $23 price target, Compass Point said.
Marsh & McLennan
was downgraded at Miller Tabak to hold from buy. Revenue growth remains soft, Miller Tabak said.
was upgraded at DA Davidson to buy from neutral. $38 price target. Stock has pulled back to an attractive level, DA Davidson said.
was upgraded to buy at TheStreet Ratings.
was upgraded at Piper Jaffray to overweight from neutral. $80 price target. Company is just beginning to drive diner growth, Piper Jaffray said.
was upgraded at ISI Group to buy from neutral. $57 price target. Industry has a lot of secular tailwinds, ISI Group said.
was downgraded at Oppenheimer to perform from outperform. See little earnings upside potential for the sector over the next six months, Oppenheimer said.
Read: The New Face of Medicaid
was downgraded at Bank of America/Merrill Lynch to underperform from buy. $64 price target. Estimates also cut, as the new analyst believes that company expectations are too high, BofA/Merrill said.
numbers were reduced at Credit Suisse. Shares are now seen reaching $182. Estimates were also cut, given the company's new guidance, Credit Suisse said. Outperform rating.
was upgraded at Deutsche Bank to buy from hold. $75 price target. Valuation call, as the stock is trading at a steep discount to its peers, Deutsche Bank said.
was downgraded at Oppenheimer to perform from outperform. Sector earnings outlook is deteriorating, Oppenheimer said.
was downgraded at Credit Suisse to neutral from outperform. Valuation call, based on a $160 price target, Credit Suisse said.
was upgraded at Bank of America/Merrill Lynch to buy from underperform. New analyst has a $48 price target. Indsutry trends could improve, along with the broader economy, BofA/Merrill said.
was upgraded at Morgan Stanley to overweight from equal-weight. $36 price target. Revenue growth should accelerate in 2014, Morgan Stanley said.
Stock Comments / EPS Changes
estimates, price target were increased at BMO Capital. Estimates were boosted through 2014. Company should see better pricing power, BMO Capital said. Outperform rating and new $508 price target.
numbers were raised at Jefferies. Shares are now seen reaching $17. Estimates were also increased on higher gold price assumptions, Jefferies said. Hold rating.
( CTM) numbers were raised at Jefferies. Shares are now seen reaching $43. Estimates were also increased on higher earnings potential with sticky contracts and favorable market environment, Jefferies said. Buy rating.
numbers were increased at BMO Capital through 2014. Customers' reaction to the 2014 models have been very positive, BMO Capital said. Outperform rating and new $74 price target.
estimates, price target were boosted at UBS. Shares are now seen reaching $142. Estimates were also upped, given higher demand for the Indian brand, UBS said. Buy rating.
numbers were raised at DA Davidson. Shares are now seen reaching $78. Estimates were also increased, as the company is seeing higher beer sales and paying a lower tax rate, DA Davidson said. Buy rating.
>To submit a news tip, email:
and become a fan on
This article was written by a staff member of TheStreet.